Skip to content
HowShorted

Prime Medicine, Inc. short interest in 2026

In 2026, Prime Medicine, Inc.'s disclosed short interest ran from 14.57% of shares outstanding on 15 Jan 2026 to 17.72% on 15 Sep 2026, a change of +3.15 percentage points. The year's high was 20.27% on 31 Aug 2026 and its low 14.57% on 15 Jan 2026, averaging 17.15% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.65 days on 30 Apr 2026. Full history: Prime Medicine, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Prime Medicine, Inc. in 2026

2026 in figures

Start of year
14.57% (15 Jan 2026)
End of year
17.72% (15 Sep 2026)
Change
+3.15 pp
High
20.27% (31 Aug 2026)
Low
14.57% (15 Jan 2026)
Average
17.15%
Highest days to cover
18.65 (30 Apr 2026)
SEC filings marked
6

Every report in 2026

Prime Medicine, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202614.57%7.30
30 Jan 202615.00%9.23
13 Feb 202615.56%10.93
27 Feb 202615.09%9.16
13 Mar 202614.85%9.8410-K filed, results (8-K)
31 Mar 202616.60%11.27
15 Apr 202616.75%16.27
30 Apr 202616.80%18.65
15 May 202616.90%11.7310-Q filed, results (8-K)
29 May 202617.06%11.21
15 Jun 202618.01%11.28
30 Jun 202619.23%9.11
15 Jul 202618.57%6.74
31 Jul 202619.30%12.90
14 Aug 202619.31%13.8210-Q filed, results (8-K)
31 Aug 202620.27%13.13
15 Sep 202617.72%12.31

See also: Prime Medicine, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.